A NOVEL STABILITY-INDICATING REVERSE PHASE LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN AND TENELIGLIPTIN IN PURE AND PHARMACEUTICAL FORMULATIONS


A. Swetha, B. Ramya Kuber

Abstract


Objective: The present method was proposed to develop a simple, sensitive, rapid, accurate and stability-indicating reverse phase liquid chromatographic method for the simultaneous estimation of metformin and teneligliptin in pure and pharmaceutical formulations.

Methods: The chromatographic separation was done on Discovery [250 mm X 4.6 mm: 5 μm is particle size] using a mobile phase composed of 0.1% orthophosphoric acid buffer: acetonitrile [65:35, v/v], the flow rate is 1 ml/min and the detection was carried out at 260 nm.

Results: The retention time of metformin and teneligliptin were found to be 2.517 min and 3.687 min, respectively. Stability indicating studies were conducting under the guidelines of an international conference on harmonization [ICH] Q1A R2 and the developed method was validated as per guidelines of ICH Q2 RI. The linearity was found in the range of concentration of 125-750 μg/ml and 5-30 μg/ml for metformin and teneligliptin. The detection of limit and quantification of limit was found to be 0.02 μg/ml and 0.07 μg/ml for metformin and 0.19 μg/ml and 0.56 μg/ml for teneligliptin, respectively.

Conclusion: A novel stability-indicating reverse-phase liquid chromatographic method for the simultaneous estimation of metformin and teneligliptin. The proposed method was adopted for the routine estimation of metformin and teneligliptin in bulk and pharmaceutical dosage forms. 


Keywords


Method validation, Estimation, Stability indicating, Metformin, Teneligliptin

| PDF | HTML |

References


Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez CC, Berger Z, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. AIM 2016;6:164-74.

Eto T, Inoue S, Kadowaki T. Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 2012;14:1040-6.

Yoshida T, Akahoshi F, Sakashita H. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2,ylcarbonyl] thiazolidine, A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg Med Chem 2012;1:5705-19.

Kaushelendra M, Himesh S, Nayak G, Patel SS, Singhai AK. Method development and validation of metformin hydrochloride in tablet dosage form. Eur J Cancer 2011;8:1309-13.

Chirag V, Amrita P. Development and validation of UV spectrophotometric method for simultaneous estimation of metformin hydrochloride and alogliptin benzoate in bulk drugs and combined dosage forms. Pharm Chem 2014;6:303-11.

Ashim KS, Denish NH, Dhanya BS, Aarti SZ, Rajesh AM. Analytical method development and validation for simultaneous estimation of teneligliptin hydrobromide hydrate and metformin hydrochloride from its pharmaceutical dosage form by three different UV spectrophotometric methods. J Appl Pharmacol Sci 2016;6:157-65.

Murthy TGK, Geethanjali J. Development of a validated rp-hplc method for simultaneous estimation of metformin hydrochloride and rosuvastatin calcium in bulk and in-house formulation. J Chromatogr Sep Tech 2014;5:252.

Doredla NR, Mannepalli C. Method development and validation of an rp-hplc method for simultaneous analysis of three component tablet formulation containing metformin hydrochloride, pioglitazone hydrochloride and glibenclamide. IJPRIF 2012;4:948-56.

Kumar TNVG, Vidyadhara S, Ashok NN, Sai SY, Lakshmi MR. Method development, validation, and stability studies of teneligliptin by rp-hplc. J Anal Sci Technol 2016;7:18.

Raja HBC, Gowri SD. Development and validation of lc-ms/ms method for quantification of teneligliptin in human plasma and its application to a pharmacokinetic study. World J Pharm Pharm Sci 2016;5:838-50.

International conference on harmonization tripartite guideline on validation of analytical procedures text and methodology: Q2(R1); 2005.

International conference on harmonization tripartite guideline on stability testing of new drug substances and products text and methodology: Q1A(R2); 2003.




About this article

Title

A NOVEL STABILITY-INDICATING REVERSE PHASE LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN AND TENELIGLIPTIN IN PURE AND PHARMACEUTICAL FORMULATIONS

Keywords

Method validation, Estimation, Stability indicating, Metformin, Teneligliptin

DOI

10.22159/ijpps.2017v9i12.21151

Date

01-12-2017

Additional Links

Manuscript Submission

Journal

International Journal of Pharmacy and Pharmaceutical Sciences
Vol 9, Issue 12, 2017 Page: 163-169

Online ISSN

0975-1491

Statistics

26 Views | 4 Downloads

Authors & Affiliations

A. Swetha
Department of Pharmaceutical Analysis, Institute of Pharmaceutical Technology, Sri Padmavathi Mahila Visvavidyalayam, Tirupathi, Andhra Pradesh, India
India

B. Ramya Kuber
Department of Pharmaceutical Analysis, Institute of Pharmaceutical Technology, Sri Padmavathi Mahila Visvavidyalayam, Tirupathi, Andhra Pradesh, India
India


Article Tools



Refbacks

  • There are currently no refbacks.